Drug Trial Radar · NCT01060267
Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial
Last checked: Nov 19, 2026Latest source record: Feb 2, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Jan 2007
Primary completion
May 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- King Abdulaziz Medical CityGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Feb 2, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objectives: Blood in stomach \& oesophagus in patients with variceal bleeding often obscures the endoscopic view \& makes endoscopic intervention difficult to perform. Erythromycin, a motilin agonist induces gastric emptying. The aim of this study was to assess the effect of Erythromycin on endoscopic visibility and its outcome.
Conditions
- Variceal Bleeding
Interventions
ErythromycinDrug
The patients in erythromycin group received intravenous bolus infusion of 125 mg of erythromycin lactobionate in 50 ml of normal saline
PlaceboDrug
patients in placebo group 50ml of normal saline over 10 minutes, 1/2 hour before endoscopy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary end point was to determine the effect of erythromycin on gastric cleansing and thereby quality of endoscopic visualization, reflecting the ease with which the procedure was performed in a clear stomach.Time frame: For upto 45 minutes from start to end of endoscopy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
King Abdul Aziz Medical City
Riyadh, Saudi Arabia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.